Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126612511 | 12661251 | 1 | I | 20160811 | 20160817 | 20160817 | PER | US-ELI_LILLY_AND_COMPANY-US201608007611 | ELI LILLY AND CO | 0.00 | M | Y | 0.00000 | 20160817 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126612511 | 12661251 | 1 | PS | HUMULIN R | INSULIN HUMAN | 1 | Unknown | 50 U, EACH MORNING | C524365A | 18780 | 50 | IU | INJECTION | QD | |||||
| 126612511 | 12661251 | 2 | SS | HUMULIN R | INSULIN HUMAN | 1 | Unknown | 60 U, EACH EVENING | C524365A | 18780 | 60 | IU | INJECTION | QD | |||||
| 126612511 | 12661251 | 3 | C | TRADJENTA | LINAGLIPTIN | 1 | Unknown | UNK, UNKNOWN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126612511 | 12661251 | 1 | Type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126612511 | 12661251 | Blood glucose decreased | |
| 126612511 | 12661251 | Underdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126612511 | 12661251 | 1 | 201508 | 0 | ||
| 126612511 | 12661251 | 2 | 201508 | 0 |